Horizon Pharma plc Announces Record Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Brean Capital Remains Bullish on Horizon Pharma (HZNP) Following 2Q Beat
August 10, 2015 6:51 AM EDTBrean Capital reiterated a Buy rating and $40 price target on Horizon Pharma (NASDAQ: HZNP) following the release of its 2Q15 earnings results. revenue was $172.8 million beating consensus estimates of $156.4. Non-GAAP EPS was $0.39 beating consensus' $0.32.
Analyst Difei Yang commented, "Given the pre-announcement of... More
Horizon Pharma (HZNP) Tops Q2 EPS by 7c
August 7, 2015 7:02 AM EDTHorizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $172.8 million versus the consensus estimate of $156.41 million.
For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.
... More